To answer CryptoCarl's question specifically:
From a clinical standpoint, Medical tourism for GLP-1 is a reasonable concern that deserves a thorough answer.
The short answer: the evidence supports this approach for most patients.
The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.
Can confirm — my data shows the same pattern.
OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Medical tourism for GLP-1.
To answer ChrisMacros: my doctor and I discussed the options and went with brand.
Quick update: I have noticed more improvement since posting this. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsSubscribing to this thread. Medical tourism for GLP-1 is exactly what I've been researching. 🙏
+1 to SleepDoc_PDX. Especially the point about "3%, triglycerides 207 → 107 mg/dL, hsCRP..." — I have seen the same in my own experience with Medical tourism for GLP-1.